Leading brain tumor experts meet for ReMission Summit 2023
Fifth annual ReMission Summit brought together top brain tumor researchers and clinicians to advance new treatments.
Posted in
Uncategorized
Search for a major depression trigger reveals a familiar face: Discovery opens new possibilities for treatments
Scientists at The Wertheim UF Scripps Institute report that a common amino acid can deliver a “slow-down” signal to the brain, likely influencing major depression, anxiety and other mood disorders in some people.
Women of Neuro: Dr. Catherine Flores
Dr. Flores is principal investigator of the Hematopoietic Stem Cell Engineering Lab at UF’s Preston A Wells Jr. Center for Brain Tumor Therapy.
Pregnant women in New Jersey ate poppy seeds, then tested positive for opioid drug use
Dr. Gary Reisfield explains the potential impact of poppy seeds on drug tests for Fox News article.
Dr. Christine Schmidt awarded AIMBE’s highest honor
Chair of biomedical engineering receives American Institute for Medical and Biological Engineering’s Galletti Award.
Aaron Sorkin reveals recent stroke diagnosis to inspire smokers to quit
Dr. Christina Wilson discusses how smoking increases risk for stroke in Fox News article.
Is Parkinson’s disease, ‘world’s fastest growing brain disease,’ mostly preventable?
Dr. Michael Okun weighs in on link between trichloroethylene and Parkinson’s disease for Fox News.
Street Psychiatrists Build Trust, Offer Hope to Homeless Patients With SMI
Dr. Dawn-Christi Bruijnzeel discusses the importance of street psychiatry for Psychiatric News article.
Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests
Dr. Michalina Janiszewska, Ph.D., a cancer biologist at The Herbert Wertheim UF Scripps Institute, offers insight into glioblastoma mechanisms.
FDA approves first ever Friedreich’s ataxia drug treatment
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
